Literature DB >> 29601413

Masked hypertension and kidney function decline: the Jackson Heart Study.

Stanford Mwasongwe1, Yuan-I Min2, John N Booth3, Ronit Katz4, Mario Sims2, Adolfo Correa2, Bessie Young4,5, Paul Muntner3.   

Abstract

BACKGROUND: Hypertension diagnosed by blood pressure (BP) measured in the clinic is associated with rapid kidney function decline (RKFD) and incident chronic kidney disease (CKD). The extent to which hypertension defined using out-of-clinic BP measurements is associated with these outcomes is unclear.
METHODS: We evaluated the association of any masked hypertension (daytime SBP/DBP ≥ 135/85 mmHg, night-time SBP/DBP ≥ 120/70 mmHg or 24-h SBP/DBP ≥ 130/80 mmHg) with RKFD and incident CKD among 676 African-Americans in the Jackson Heart Study with clinic-measured SBP/DBP less than 140/90 mmHg who completed ambulatory BP monitoring in 2000-2004. RKFD was defined as a decline in estimated glomerular filtration rate (eGFR) at least 30% and incident CKD was defined as development of eGFR less than 60 ml/min per 1.73 m with an at least 25% decline in eGFR between 2000-2004 and 2009-2013.
RESULTS: The mean age of participants was 57.6 years, 28.8% were men and 52.7% had any masked hypertension. After a median follow-up of 8 years, 13.8 and 8.6% of participants had RKFD and incident CKD, respectively. In unadjusted analyses, masked hypertension was associated with an increased odds for incident CKD [odds ratio (OR) 2.20, 95% confidence interval (CI) 1.22, 3.97]. This association remained statistically significant after adjustment for demographic characteristics, baseline eGFR and albumin-to-creatinine ratio (OR 1.95, 95% CI 1.04, 3.67) but was eliminated after propensity score adjustment (OR 1.62, 95% CI 0.87, 3.00). There was no association between masked hypertension and RKFD.
CONCLUSION: Masked hypertension may be associated with the development of CKD in African-Americans.

Entities:  

Mesh:

Year:  2018        PMID: 29601413      PMCID: PMC5990961          DOI: 10.1097/HJH.0000000000001727

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  45 in total

1.  Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study.

Authors:  Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong
Journal:  Am J Med Sci       Date:  2004-09       Impact factor: 2.378

2.  Study design for genetic analysis in the Jackson Heart Study.

Authors:  James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

3.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

4.  Long-term risk of sustained hypertension in white-coat or masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Rita Facchetti; Fabiana Madotto; Fosca Quarti-Trevano; Hernan Polo Friz; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

5.  Clinical correlates of ambulatory BP monitoring among patients with CKD.

Authors:  Satoshi Iimuro; Enyu Imai; Tsuyoshi Watanabe; Kosaku Nitta; Tadao Akizawa; Seiichi Matsuo; Hirofumi Makino; Yasuo Ohashi; Akira Hishida
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

6.  Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

Authors:  R Sega; G Trocino; A Lanzarotti; S Carugo; G Cesana; R Schiavina; F Valagussa; M Bombelli; C Giannattasio; A Zanchetti; G Mancia
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

8.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

9.  Evaluating different criteria for defining a complete ambulatory blood pressure monitoring recording: data from the Jackson Heart Study.

Authors:  Samantha G Bromfield; John N Booth; Matthew S Loop; Joseph E Schwartz; Samantha R Seals; Stephen J Thomas; Yuan-I Min; Gbenga Ogedegbe; Daichi Shimbo; Paul Muntner
Journal:  Blood Press Monit       Date:  2018-04       Impact factor: 1.444

10.  Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jade S Hiramoto; Ronit Katz; Carmen A Peralta; Joachim H Ix; Linda Fried; Mary Cushman; David Siscovick; Walter Palmas; Mark Sarnak; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2012-05-04       Impact factor: 8.860

View more
  7 in total

1.  Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report.

Authors:  Adamasco Cupisti; R M Bruno; A Puntoni; E Varricchio; E Giglio; O Meniconi; C Zullo; M Barsotti; M F Egidi; L Ghiadoni
Journal:  Intern Emerg Med       Date:  2019-06-17       Impact factor: 3.397

2.  Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Mahboob Rahman; Xue Wang; Joshua D Bundy; Jeanne Charleston; Debbie Cohen; Jordana Cohen; Paul E Drawz; Lama Ghazi; Edward Horowitz; James P Lash; Sarah Schrauben; Matthew R Weir; Dawei Xie; Raymond R Townsend
Journal:  J Am Soc Nephrol       Date:  2020-09-24       Impact factor: 10.121

3.  Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort.

Authors:  Hyeonjin Kang; Song Hee Hong
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

4.  Twenty-four-hour versus clinic blood pressure levels as predictors of long-term cardiovascular and renal disease outcomes among African Americans.

Authors:  Srividya Kidambi; Tao Wang; Thomas Chelius; Irene Nunuk; Priyanka Agarwal; Purushottam Laud; David Mattson; Allen W Cowley; Mingyu Liang; Theodore Kotchen
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

5.  Kidney Function and Aortic Stiffness, Pulsatility, and Endothelial Function in African Americans: The Jackson Heart Study.

Authors:  Harsha S Nagarajarao; Solomon K Musani; Keith E Cobb; James D Pollard; Leroy L Cooper; Anshul Anugu; Yuichiro Yano; Josiah A Moore; Connie W Tsao; Albert W Dreisbach; Emelia J Benjamin; Naomi M Hamburg; Ramachandran S Vasan; Gary F Mitchell; Ervin R Fox
Journal:  Kidney Med       Date:  2021-07-14

Review 6.  State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19.

Authors:  Keith C Ferdinand; Thanh N Vo; Melvin R Echols
Journal:  Am J Prev Cardiol       Date:  2020-07-15

Review 7.  Masked Hypertension: Lessons for the Future.

Authors:  Krishnam R Penmatsa; Mohan Biyani; Ankur Gupta
Journal:  Ulster Med J       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.